FB2026_02 , released June 18, 2026
Reference Report
Open Close
Reference
Citation
Han, S., Xiu, M., Li, S., Shi, Y., Wang, X., Lin, X., Cai, H., Liu, Y., He, J. (2023). Exposure to cytarabine causes side effects on adult development and physiology and induces intestinal damage via apoptosis in Drosophila.  Biomed. Pharmacotherapy 159(): 114265.
FlyBase ID
FBrf0255673
Publication Type
Research paper
Abstract
Cytarabine (Ara-C) is a widely used drug in acute myeloid leukemia (AML). However, it faces serious challenges in clinical application due to serious side effects such as gastrointestinal disorders and neurologic toxicities. Until now, the mechanism of Ara-C-induced damage is not clear. Here, we used Drosophila melanogaster (fruit fly) as the in vivo model to explore the side effects and mechanism of Ara-C. Our results showed that Ara-C supplementation delayed larval development, reduced lifespan, impaired locomotor capacity, and increased susceptibility to stress response in adult flies. In addition, Ara-C led to the intestinal morphological damage and ROS accumulation in the guts. Moreover, administration of Ara-C promoted gene expressions of Toll pathway, IMD pathway, and apoptotic pathway in the guts. These findings raise the prospects of using Drosophila as in vivo model to rapidly assess chemotherapy-mediated toxicity and efficiently screen the protective drugs.
PubMed ID
PubMed Central ID
Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    Biomed. Pharmacotherapy
    Title
    Biomedicine & Pharmacotherapy
    Publication Year
    1982-
    ISBN/ISSN
    0753-3322
    Data From Reference
    Alleles (1)
    Chemicals (2)
    Genes (1)
    Human Disease Models (1)
    Transgenic Constructs (1)